Search Results - "Kehl, Niklas"
-
1
Cancer-type organic anion transporting polypeptide 1B3 (Ct-OATP1B3) is localized in lysosomes and mediates resistance against kinase inhibitors
Published in Molecular pharmacology (01-12-2022)“…Cancer-type organic anion transporting polypeptide 1B3 (Ct-OATP1B3), a splice variant of the hepatic uptake transporter OATP1B3 (liver-type; Lt-OATP1B3), is…”
Get full text
Journal Article -
2
Intrathecal activation of CD8+ memory T cells in IgG4‐related disease of the brain parenchyma
Published in EMBO molecular medicine (09-08-2021)“…IgG4‐related disease (IgG4‐RD) is a fibroinflammatory disorder signified by aberrant infiltration of IgG4‐restricted plasma cells into a variety of organs…”
Get full text
Journal Article -
3
IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells
Published in Journal for immunotherapy of cancer (01-10-2022)“…Multiple myeloma (MM) is a hematological malignancy originating from malignant and clonally expanding plasma cells. MM can be molecularly stratified, and its…”
Get full text
Journal Article -
4
857 Dose- and time-dependent immune cell dynamics in irradiated gliomas
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundResection followed by radio-chemotherapy remains the mainstay of standard-of-care for patients with malignant brain tumors. Immunotherapies such as…”
Get full text
Journal Article -
5
Rhodium‐Catalyzed Anti‐Markovnikov Transfer Hydroiodination of Terminal Alkynes
Published in Angewandte Chemie International Edition (23-01-2023)“…A rhodium‐catalyzed anti‐Markovnikov hydroiodination of aromatic and aliphatic terminal alkynes is reported. Depending on the choice of ligand and substrate,…”
Get full text
Journal Article -
6
Dysfunctional dendritic cells limit antigen-specific T cell response in glioma
Published in Neuro-oncology (Charlottesville, Va.) (14-02-2023)“…Dendritic cells (DC), the most potent professional antigen presenting cells capable of effective cross-presentation, have been demonstrated to license T helper…”
Get full text
Journal Article -
7
Rhodium‐katalysierte Anti‐Markovnikov Hydroiodierung von Terminalen Alkinen
Published in Angewandte Chemie (23-01-2023)“…Wir beschreiben eine Rhodium‐katalysierte anti‐Markovnikov Hydroiodierung von terminalen aromatischen und aliphatischen Alkinen. Je nach Wahl des Liganden und…”
Get full text
Journal Article -
8
The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients
Published in Cancer cell (10-04-2023)“…Bispecific T cell engagers (TCEs) have shown promise in the treatment of various cancers, but the immunological mechanism and molecular determinants of primary…”
Get full text
Journal Article -
9
P-022 Discovery of Shared, MHC-Promiscuous Antigens in Multiple Myeloma Patients
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)Get full text
Journal Article -
10
A supervised machine-learning approach for the efficient development of a multi method (LC-MS) for a large number of drugs and subsets thereof: focus on oral antitumor agents
Published in Clinical chemistry and laboratory medicine (26-01-2024)“…Accumulating evidence argues for a more widespread use of therapeutic drug monitoring (TDM) to support individualized medicine, especially for therapies where…”
Get more information
Journal Article -
11
Mapping the Multiple Myeloma T Cell Landscape By Immunotherapeutic Perturbation Reveals Mechanism and Determinants of Response to Bispecific T Cell Engagers
Published in Blood (23-11-2021)“…Immunotherapies have transformed the clinical care of patients with cancer. Bispecific T cell engagers (TCEs) have recently entered early-phase clinical trials…”
Get full text
Journal Article -
12
Tumor Reactive T Cells Reside in the Bone Marrow and Are Associated with Clinical Response to Hematological Malignancies
Published in Blood (02-11-2023)“…T cell receptors (TCRs) play a crucial role in orchestrating cellular immunity in both health and disease, particularly in the context of cancer. Although…”
Get full text
Journal Article -
13
Entwicklung, Optimierung, Validierung und Anwendung Einer LC-MS Methode für die Simultane Quantifizierung Einer Vielzahl von Oralen Antitumortherapeutika In Humanplasma als Basis für Eine Zukünftige, Routinemäßige Expositionsabschätzung von Tumorpatienten
Published 01-01-2024“…Tumorerkrankungen sind für etwa 25 % aller Todesfälle in Deutschland verantwortlich und nach Herz-Kreislauf-Erkrankungen die zweithäufigste Todesursache. Die…”
Get full text
Dissertation -
14
Discovery of Tumor Reactive T Cell Receptors in Newly Diagnosed Multiple Myeloma
Published in Blood (15-11-2022)Get full text
Journal Article -
15
-
16
An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human Plasma
Published in Cancers (16-12-2021)“…Oral anticancer drugs have led to significant improvements in the treatment of multiple tumor entities. However, in patients undergoing oral antitumor therapy,…”
Get full text
Journal Article -
17
Abstract 14: Identification of tumor-reactive T cell receptors through functional single cell interaction analyses for personalized T cell therapy
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract Innovative immunotherapy approaches such as adoptive transfer of chimeric antigen receptor (CAR) T cells or tumor infiltrating lymphocytes (TILs) have…”
Get full text
Journal Article -
18
OAB-027: Discovery of tumor-reactive T cell receptors in multiple myeloma
Published in Clinical lymphoma, myeloma and leukemia (01-08-2022)Get full text
Journal Article -
19
OAB-002: The preexisting T cell landscape determines response to T cell-engagers therapy in multiple myeloma
Published in Clinical lymphoma, myeloma and leukemia (01-08-2022)Get full text
Journal Article -
20
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance
Published in Science immunology (03-05-2024)“…Understanding the mechanisms that regulate T cell immunity is critical for the development of effective therapies for diseases associated with T cell…”
Get more information
Journal Article